Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $6.07 million which missed the analyst consensus estimate of $7.85 million by 22.64 percent. This is a 34.83 percent decrease over sales of $9.32 million the same period last year.
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $6.07 million which missed the analyst consensus estimate of $7.85 million by 22.64 percent. This is a 34.83 percent decrease over sales of $9.32 million the same period last year.
Comments